icd 10 code for afp tumor marker screening

Full Answer

What is the ICD 10 code for abnormal tumor markers?

Other abnormal tumor markers. R97.8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM R97.8 became effective on October 1, 2018.

Can AFP be used as a tumor marker during pregnancy?

The use of AFP as a tumor marker in pregnant females is not recommended. *Pediatric range is based on full term neonates, values for premature infants may be higher. The use of AFP as a tumor marker in pregnant females is not recommended.

What are the PubMed numbers for tumor markers in germ cell malignancies?

PubMed 7684823 18. Klepp O. Serum tumor markers in testicular and extragonadal germ cell malignancies. Scand J Clin Lab Invest Suppl. 1991; 206:28-41. PubMed 1947758 19. Sturgeon C. Practice guidelines for tumor marker use in the clinic. Clin Chem. 2002 Aug; 48 (8):1151-1159. PubMed 12142367 20.

What is the volume of AFP serum used for cancer testing?

0.7 mL ( Note: This volume does not allow for repeat testing.) If a red-top tube is used, transfer separated serum to a plastic transport tube. The most important application of AFP testing in cancer management is for testicular cancer.

What diagnosis will cover AFP?

AFP is useful for the diagnosis of hepatocellular carcinoma in high-risk patients (such as alcoholic cirrhosis, cirrhosis of viral etiology, hemochromatosis, and alpha 1-antitrypsin deficiency) and in separating patients with benign hepatocellular neoplasms or metastases from those with hepatocellular carcinoma and, as ...

What is the ICD-10 code for elevated AFP?

R77. 2 - Abnormality of alphafetoprotein | ICD-10-CM.

Is AFP a tumor marker?

An AFP tumor marker test may be used to: Help confirm or rule out a diagnosis of liver cancer or cancer of the ovaries or testicles. Monitor cancer treatment. AFP levels often go up if cancer is spreading and go down when treatment is working.

What is the ICD-10 code for rising tumor markers?

R97. 8 - Other abnormal tumor markers. ICD-10-CM.

What ICD-10 codes cover AFP?

Abnormality of alphafetoprotein R77. 2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R77. 2 became effective on October 1, 2021.

What is the CPT code for alpha-fetoprotein tumor marker?

LOINC MapOrder CodeOrder Code NameResult LOINC002253AFP, Serum, Tumor Marker53962-7

What is AFP Screening?

Alpha-fetoprotein screening is a blood test that measures the level of alpha-fetoprotein in the mothers' blood during pregnancy. AFP is a protein normally produced by the fetal liver and is present in the fluid surrounding the fetus (amniotic fluid), and crosses the placenta into the mother's blood.

What is an AFP tumor?

AFP is 1 of several tumor markers. Tumor markers are molecules in the blood that are higher when a person has certain cancers. AFP is found mainly in liver cancer and germ cell tumors of the testicles or ovaries, which are rare. These are found in the pineal gland in the brain.

What is an AFP test?

An AFP blood test is used to check a developing fetus for risk of birth defects and genetic disorders, such as neural tube defects or Down syndrome.

What is R79 89?

ICD-10 code R79. 89 for Other specified abnormal findings of blood chemistry is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .

What is the ICD-10 code for CA 19-9?

NCD - Tumor Antigen by Immunoassay - CA 19-9 (190.30) The .

What diagnosis covers CA 19-9?

CA 19-9 is a type of tumor marker. Tumor markers are substances made by cancer cells or by normal cells in response to cancer in the body. Healthy people can have small amounts of CA 19-9 in their blood. High levels of CA 19-9 are often a sign of pancreatic cancer.

Special Instructions

If patient is pregnant, include approximate gestational age on the test request form and order test 010801. Values obtained with different assay methodologies should not be used interchangeably in serial testing. It is recommended that only one assay method be used consistently to monitor a patient's course of therapy.

Expected Turnaround Time

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Collection

If a red-top tube is used, transfer separated serum to a plastic transport tube.

Limitations

The measured AFP value of a patient's sample can vary depending on the test procedure used. The laboratory finding must, therefore, always contain a statement on the AFP assay method used.

Reference Interval

Tumor marker normals: 0.0−8.3 ng/mL. Normal values apply only to males and to nonpregnant females. These results are not interpretable for pregnant females.

Additional Information

The Elecsys AFP assay is intended for the in vitro quantitative determination of α 1 -fetoprotein in human serum and plasma to aid in the management of patients with nonseminomatous germ cell tumors. 12 The determination of AFP to screen the general population for cancer is, however, not to be recommended.

Footnotes

1. Javadpour N, McIntire KR, Waldmann TA. Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: A prospective study. Cancer. 1978 Dec; 42 (6):2768-2772. PubMed 83187